Bio Nebraska and Monsanto to Host Ag Meeting at Water Utilization Learning Center

Monsanto’s Water Utilization Learning Center is the first of its kind in agriculture. The $6 million facility was developed by Monsanto to share industry-leading knowledge and research, particularly in the area of water management. The Water Utilization Learning Center allows farmers and other stakeholders the opportunity to learn about water-use efficiency technologies in agriculture in … Read Full Press Release

Biotech Developer Divine Skin (DSKX) Announces New Brazilian Division to Exploit Latin American Markets

DS Laboratories, Divine Skin’s first brand, begins Brazilian marketing operations with several level-1 cosmetics, including its Nia radiant-color shampoo and conditioner and Nirena pH-balanced feminine cleanser. Oligo.DX eliminates the unsightly appearance of dimpled fat, revealing smoother, firmer thighs, buttocks, and hips. The secret of its success is delivering active ingredients deeper, into lower layers of … Read Full Press Release

SoCalBio Cloud Computing Conference to Focus on Helping Bioscience Firms Improve Operational Efficiency

The Southern California Biomedical Council (SoCalBio) has announced the lineup of speakers for its first conference on cloud computing, which will be held Thursday, February 24th at the Jonathan Club in downtown Los Angeles. The day-long conference will help small and mid-size companies take advantage of “cloud” resources and other advancements in information technology that … Read Full Press Release

ConjuChem Resumes Operations Led by Dr. Patrick Soon-Shiong

ConjuChem, LLC, a biotechnology company dedicated to the discovery of novel therapeutics, announced today the relaunch of the company under new management, headed by healthcare visionary and business leader Patrick Soon-Shiong, M.D. ConjuChem’s product development will be led by a team that has a proven track record of successfully developing and commercializing Abraxane(R), itself a … Read Full Press Release

XOMA Announces Presentation and Webcast at Jefferies 2011 Global Healthcare Conference

XOMA is a leader in the discovery and development of novel antibody therapeutics. The company’s proprietary product pipeline includes: Certain statements contained herein concerning timing of initiation of clinical trials, or interim or other results of early-stage clinical trials, or that otherwise relate to future periods are forward-looking statements within the meaning of Section 27A … Read Full Press Release

AEGY, ONCY, AMBS and SFOR is/are the Daily Market Mover(s) for December 14th from

ALTERNATIVE ENERGY PARTNERS INCORPORATED (OTCBB: AEGY) “Up 100.00% in morning trading” Alternative Energy Partners, Inc., a development stage company, engages in the energy production and management business in the United States. The company focuses on providing commercial buildings with advanced solar thermal energy production systems allowing businesses to use alternative energy sources. It intends to … Read Full Press Release

Ultragenyx Announces Collaboration With Kyowa Hakko Kirin to Develop and Commercialize Phase 2-Stage KRN23 for X-Linked Hypophosphatemia

XLH is a rare metabolic bone disorder caused by excessive loss of phosphate in the urine leading to severe hypophosphatemia and poor bone growth and mineralization.XLH patients have low serum phosphate levels due to high levels of FGF23, a hormone that represses the reabsorption of phosphate from the urine.KRN23 is intended to bind to and … Read Full Press Release

Research and Markets: Global Transdermal Drug Delivery Market to 2020: Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and Swot Investigation

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 320 tables & figures over 280 pages. – By Company (e.g., JANSSEN, MYLAN, ACTAVIS, GLAXOSMITHKLINE, BAYER, NOVARTIS, NOVEN, LAVIPHARM, PROSTRACKEN, NITTO DENTO) – By Geography (Global, USA) – By … Read Full Press Release

Charles River Associates (CRA) Expands Life Sciences Practice in the US and Europe

Mr. Cole has more than 17 years of experience advising large and mid-tier pharmaceutical and biotech companies and academic institutions in such areas as strategy development and implementation. His areas of expertise focus on R&D, in particular R&D strategy, performance improvement, operating model design, and innovation management. He also has extensive experience assisting business development … Read Full Press Release

Visterra Appoints Two Industry Leaders to its Board of Directors

Visterra, Inc., a clinical-stage biotechnology company, today announced the appointment of Bernadette Connaughton, Head, European Markets, Canada and Australia of Bristol-Myers Squibb, and Steven Holtzman, former Executive Vice President, Corporate Development of Biogen, to the company’s board of directors. Ms. Connaughton and Mr. Holtzman each bring more than 30 years of strategic, operational and management … Read Full Press Release

Sirona Biochem Announces Close of Oversubscribed Private Placement

Dr. Howard Verrico, CEO, has participated in the Private Placement with the purchase of 1,000,000 Units and upon completion, owns 5,951,250 common shares. All securities issued under the placement are subject to statutory hold periods expiring on February 26, 2018. Proceeds of the placement will be used for general working capital. About Sirona Biochem Corp. … Read Full Press Release

Pharming provides update on outstanding number of shares

LEIDEN, NETHERLANDS — (Marketwire) — 09/11/09 — Biotech companyPharming Group NV (“Pharming”) (NYSE Euronext: PHARM) today providedan update on its outstanding number of shares following transactionswith YA Global Master SPV LTD (“YA Global”). Under the Standby Equity Distribution Agreement with YA Global,Pharming issued a total of 1,852,230 ordinary shares for a cashconsideration of EUR 1.0 … Read Full Press Release

Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100.

This collaboration is a milestone-based approach in which NCI will first confirm the anti-cancer activity of LB-100 in an animal model of glioblastoma multiforme, the most common brain tumor of adults, and conduct an initial exploratory toxicology study in an animal model. At milestone intervals, the SAC will re-evaluate project progress before considering assignment of … Read Full Press Release

Response Genetics, Inc. Announces Appointment of Company President

“With her strong background in the diagnostics industry, Christine’s strategic vision and considerable business experience have helped companies successfully develop, launch and market products,” said Ms. Danenberg, CEO. “And with our current growth rate in the double digits, her addition to the senior management team will help Response Genetics expand its market and realize its … Read Full Press Release

Life Sciences Industry Footprint Driven By R&D Productivity, Emerging Markets Sales

With downward pricing pressure and the need to control facility costs, life sciences companies are making calculated and strategic decisions for their facilities investments. The historical dynamic of mature-market R&D discovery vs. offshoring lower-value operations is slowly evolving as emerging markets increasingly drive consumer demand. “We are seeing even greater bifurcation of location strategies in … Read Full Press Release

Weight Loss Programs So Often Do Not Work! Why?

September 4, 2013 – Beaverton, Oregon — “What is interesting about <a href=”” target=”_blank”>weight loss</a> is that everyone has a trick up their sleeves. Some claim you cannot possibly lose weight without exercising for at least 2 hours a day”, while others claim that the only way to lose weight is to limit diets to … Read Full Press Release

Research and Markets: Global and Chinese Xylitol Industry Report 2013

The ‘Global and Chinese Xylitol Industry Report 2013’ is a professional and in-depth study on the current state of the global xylitol industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions, classifications, applications, industry chain structure and overview. Xylitol market analysis is provided for both … Read Full Press Release

Cosmederm Bioscience Introduces Steve Massah as New Chief Operating Officer

Cosmederm Bioscience, a leading specialty pharmaceutical company focused on dermatology and pain management, has hired Steve Massah as the company’s new Chief Operating Officer. As COO, Massah will provide strategic and tactical leadership, and management of manufacturing, product development, quality and product shipment and logistics. His work will ensure compliance with all government regulations and … Read Full Press Release

Antisense RNAi Therapeutics Market Emerging Biotechnologies Report Available at

Alnylam Pharmaceuticals, Antisense Therapeutics, Arrowhead Research Corporation, AuraSense Therapeutics, BioMarin Pharmaceuticals, Dicerna Pharmaceuticals, Gene Signal International SA, Idera Pharmaceuticals, InDex Pharmaceuticals AB, Isarna Therapeutics GmbH, Isis Pharmaceuticals, Miragen Therapeutics, Mirna Therapeutics, Moderna Therapeutics, Mologen AG, Oncogenex Pharmaceuticals, Quark Pharmaceuticals, Regulus Therapeutics, RXi Pharmaceuticals, Sarepta Therapeutics, Silence Therapeutics Plc, Sirnaomics, Sterna Biologicals GmbH, Sylentis SA and … Read Full Press Release

Lion Biotechnologies Reports Third Quarter 2016 Financial Results and Provides Corporate Update

SAN CARLOS, CA–(Marketwired – November 04, 2016) – “Lion continues building momentum in broadening the utility of our TIL technology in new indications through internal R&D as well as with our collaborators. We recently announced our collaboration with the Karolinska Institute which expands the utility of TIL into two new indications, glioblastoma and pancreatic cancer. … Read Full Press Release

Bioimaging Market 2017 Global Analysis, Opportunities and Forecast To 2021

Bioimaging -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021 Bioimaging Industry Description Bioimaging report covers Applications and the various modalities of Bioimaging for the global market. The Applications of Bioimaging include Diagnostics and Research and Development. The report provides an in depth analysis of each of the applications and modalities … Read Full Press Release